When the FDA recently cleared Convatec’s InnovaMatrix® PD particulate placental extracellular matrix medical device for wound management, it marked a breakthrough as the first and only medical device of its kind. InnovaMatrix® PD joins Convatec’s InnovaMatrix® AC, InnovaMatrix® FS and InnovaBurn® as the first and only next-generation placental-derived medical devices designed specifically to help manage hard-to-heal wounds. The new technology the InnovaMatrix® products offer is exciting news for patients with complex surgical wounds, chronic stalled wounds and burns.
The unique InnovaMatrix® ECM has all the inherent benefits of the placenta1,2 with the consistency, reliability, and safety profile of a medical device3,4. Convatec’s leading-edge technology and proprietary processing methods result in a thoroughly decellularized scaffold while maintaining the functional proteins that play an important role in all stages of wound healing.
Learn more about how to offer your patients the latest breakthrough in wound management. To order an InnovaMatrix® product, please visit https://triadls.com or contact Convatec’s Customer Service Team at 901-333-6000 x1. For a full listing of indications, please see the Instructions for Use.
1. Shaifur Ra, M., Islam, R., Asaduzzama, S.M., & Shahedur R, M. (2015). Properties and Therapeutic Potential of Human Amniotic Membrane. Asian Journal of Dermatology, 7(1), 1-12. doi: 10.3923/ajd.2015.1.12 2. Fairbairn, N. G., Randolph, M. A., & Redmond, R. W. (2014). The clinical applications of human amnion in plastic surgery. Journal of Plastic, Reconstructive & Aesthetic Surgery, 67(5), 662-675. 3. K193552 510(k) Summary 4. Data on file -RDR-002